纤维蛋白封闭剂对袖状胃切除术后钉线并发症的预防效果:前瞻性随机试验
该前瞻性随机对照试验纳入586例首次袖状胃切除术患者,1:1随机分为纤维蛋白封闭剂组和对照组,评估纤维蛋白封闭剂对钉线并发症的预防效果。结果显示两组钉线并发症发生率无显著差异(1.3% vs 2%,P=0.52),所有次要终点亦无差异。
要点
- 纤维蛋白封闭剂未降低袖状胃切除术后钉线并发症发生率
- 两组并发症率、死亡率、再手术率、住院时间和再入院率均无显著差异
- 未发现钉线并发症的危险因素
核心结论
- 袖状胃切除术后钉线并发症的发生率与是否使用纤维蛋白封闭剂无关。
研究设计与样本
- 前瞻性、意向性治疗、随机、两中心研究,纳入586例首次袖状胃切除术患者,1:1随机分为纤维蛋白封闭剂组(293例)和对照组(293例)。
主要发现
- 意向性治疗分析中,纤维蛋白封闭剂组与对照组钉线并发症发生率相似(1.3% vs 2%,P=0.52)。
- 并发症率(5.4% vs 5.1%,P=0.85)、死亡率(0.3% vs 0%,P=0.99)、胃漏率(0.3% vs 1.3%,P=0.18)、术后出血/血肿率(1% vs 0.7%,P=0.68)、再手术率(1% vs 0.3%,P=0.32)均无显著差异。
- 两组住院时间均为1天(P=0.89),再入院率相似(5.1% vs 3.4%,P=0.32)。
- 未发现钉线并发症的危险因素。
临床怎么用
- 袖状胃切除术中常规应用纤维蛋白封闭剂预防钉线并发症缺乏证据支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Evaluate the effectiveness of the use of fibrin sealant (FS) for preventing the development of staple line complications (SLCs) after sleeve gastrectomy (SG). BACKGROUND: There is no consensus on the best means of preventing SLCs after SG. METHODS: This was a prospective, intention-to-treat, randomized, 2 center study of a group of 586 patients undergoing primary SG (ClinicalTrials.gov identifier: NCT01613664) between March 2014 and June 2017. The 1:1 randomization was stratified by center, age, sex, gender, and body mass index, giving 293 patients in the FS group and 293 in the control group (without FS). The primary endpoint (composite criteria) was the incidence of SLCs in each of the 2 groups. The secondary criteria were the mortality rate, morbidity rate, reoperation rate, length of hospital stay, readmission rate, and risk factors for SLC. RESULTS: There were no intergroup differences in demographic variables. In an intention-to-treat analysis, the incidence of SLCs was similar in the FS and control groups (1.3% vs 2%, respectively; P = 0.52). All secondary endpoints were similar: complication rate (5.4% vs 5.1%, respectively; P = 0.85), mortality rate (0.3% vs 0%, respectively; P = 0.99), GL rate (0.3% vs 1.3%, respectively; P = 0.18), postoperative hemorrhage/hematoma rate (1% vs 0.7%, respectively; P = 0.68), reoperation rate (1% vs 0.3%, respectively; P = 0.32). Length of stay was 1 day in both groups (P = 0.89), and the readmission rate was similar (5.1% vs 3.4%, respectively; P = 0.32). No risk factors for SLCs were found. CONCLUSION: The incidence of postoperative SLCs did not appear to depend on the presence or absence of FS.
引用
- Rebibo L, Dhahri A, Chati R, et al. Effectiveness of Fibrin Sealant Application on the Development of Staple Line Complications After Sleeve Gastrectomy: A Prospective Randomized Trial. Ann Surg. 2018. PMID: 30080735. doi:10.1097/SLA.0000000000002892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。